GPT and liver disorder: A multicenter retrospective study including 6,052 patients with various liver disease (8% Hepatitis B Virus (HBV) infected) demonstrated that PPC efficiently decreased alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels in patients with liver diseases regardless of the status of HBV infection.